Evidence mapPaperPMID 41540409Full record

ArticleBMC medical genomics2026

North Carolina primary care provider perspectives on expanded genomic screening in children.

Elizabeth Kathleen Branch, Megan C Roberts, Margaret Waltz, Neal A deJong, Laura V Milko, Ann Katherine Foreman, Kimberly Foss, Stefanija Giric, Marcella H Boynton, Jonathan S Berg and 1 more

Abstract read
In one paragraph

Article in BMC medical genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Elizabeth Kathleen BranchUNC School of Medicine, Chapel Hill, NC, USA.
Megan C RobertsDivision of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA.
Margaret WaltzDepartment of Social Medicine and Center for Bioethics, UNC School of Medicine, Chapel Hill, NC, USA.
Neal A deJongDivision of General Pediatrics and Adolescent Medicine, UNC School of Medicine, 321 S Columbia St, Chapel Hill, NC, 27599, USA.
Laura V MilkoDepartment of Genetics, UNC School of Medicine, Chapel Hill, NC, USA.
Ann Katherine ForemanDepartment of Genetics, UNC School of Medicine, Chapel Hill, NC, USA.
Kimberly FossDepartment of Genetics, UNC School of Medicine, Chapel Hill, NC, USA.
Stefanija GiricDepartment of Genetics, UNC School of Medicine, Chapel Hill, NC, USA.
Marcella H BoyntonDivision of General Medicine and Clinical Epidemiology, UNC School of Medicine, Chapel Hill, NC , United States.
Jonathan S BergDepartment of Genetics, UNC School of Medicine, Chapel Hill, NC, USA.
Samantha SchillingDivision of General Pediatrics and Adolescent Medicine, UNC School of Medicine, 321 S Columbia St, Chapel Hill, NC, 27599, USA. Samantha_Schilling@med.unc.edu.

Funding

Age-based genomic screening in newborns, infants, and children: a novel paradigm in public health genomicsR01HG012271 · UNIV OF NORTH CAROLINA CHAPEL HILL · 2025 to 2025
$866k
National Institute of Health R01HG012271NHGRI NIH HHS R01 HG012271
6 · The paper itself

Abstract

backgroundExpanding pediatric genomic screening beyond current newborn screening presents both opportunities and challenges to primary care providers. We are developing a novel paradigm called Age-Based Genomic Screening (ABGS), which will incorporate targeted genomic sequencing for select, highly actionable genetic conditions into routine care at relevant time-points throughout childhood.

methodsWe disseminated an electronic survey to family medicine and pediatric primary care clinicians in North Carolina to identify potential ABGS implementation determinants and strategies to address them. Survey items were modeled on constructs previously identified as important to genomic medicine and assessed perceived utility, benefits, barriers, and facilitators of implementing targeted genomic screening in pediatric primary care. Data were analyzed using descriptive statistics and content analysis, as appropriate.

resultsA total of 93 individuals completed the survey. Over 85% of respondents agreed that genomic screening was important and impactful in their patient care but about 30% lacked confidence in their ability to implement it in their practice. The most cited benefits of the ABGS program were related to readiness for implementation and the evidence, strength, and quality of the intervention. The most concerning barriers included cost for patients and available resources, with 87% and 75% of respondents having extreme or moderate concern for these barriers, respectively.

conclusionsOur findings have implications both for the design of the ABGS pilot program and directions for future research in genomic implementation. In particular, the blueprint for the pilot program must include specific plans for ensuring primary care providers have the time and resources available for shared decision making with their patients about engaging in genomic screening. CLINICAL TRIAL REGISTRY: Clinical trial number: not applicable

Indexed as

Attitude of Health PersonnelGenetic TestingGenomicsHealth PersonnelPrimary Health CareChildFemaleHumansInfant, NewbornMaleNorth CarolinaSurveys and QuestionnairesGenomic screeningImplementation sciencePediatric primary care

Identifiers

PMID41540409
PMCPMC12895586

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.